Pharmacogenetics and Genomics

Papers
(The H4-Index of Pharmacogenetics and Genomics is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Clozapine metabolism may be affected by Gilbert’s syndrome: case report and discussion86
Establishing national reference materials for genetic testing of cytochrome P45011
MEG3 in hematologic malignancies: from the role of disease biomarker to therapeutic target11
Novel variant in Nudix hydrolase 15 gene influences 6-mercaptopurine toxicity in childhood acute lymphoblastic leukemia patients11
Effect of CYP2C19 genetic variants on bleeding and major adverse cardiovascular events in a cohort of Arab patients undergoing percutaneous coronary intervention and stent implantation9
Luteal phase stimulation in double ovarian stimulation cycles is not affected by the follicle-stimulating hormone (FSH) receptor genotype: double ovarian stimulation is beneficial independently of the8
Impact of CYP3A5 genotype on de-novo LCP tacrolimus dosing and monitoring in kidney transplantation8
The functional role of inherited CDKN2A variants in childhood acute lymphoblastic leukemia8
0.085144996643066